Introduction: Scale-up of antiretroviral therapy (ART) for human immunodeficiency virus (HIV) 
INTRODUCTION
The tuberculosis (TB) epidemic remains a major global health problem despite strong worldwide efforts to control it [1] . In 2012, an estimated 8.6 million people developed TB globally and 1.3 million died from the disease [2] . South Africa has the highest incidence rate per capita with 1 new case for every 100 people each year [2] . Moreover, South Africa has the highest burden of people coinfected with TB and Human Immunodeficiency Virus (HIV) [2, 3] . The HIV epidemic has been an important driver of the incidence of TB, attributing to the four-fold increase in TB notification in South Africa between 1986 and 2007 [4] .
In recent years the antiretroviral therapy (ART) programme for HIV-infection has expanded dramatically in South Africa [5] , accompanied by a higher CD4 count threshold for treatment initiation [6] and resulting in more HIV-infected patients initiated on ART [7] . Several studies show a reduction in TB incidence among HIV-infected patients in the context of this ART scale-up in South Africa [8] [9] [10] .
There is evidence for a decrease in incidence of pulmonary TB (PTB) during ART scale-up in South Africa. Nanoo et al reports a 9% decline of PTB between 2008 and 2012, coincided with an increase in ART-coverage [11] . One study reports that the decline in PTB during ART scale-up contributed to an increase in life expectancy amongst HIV-infected patients [12] . However, contrary to PTB, there is no data on the effect of ART scale-up on the incidence of extrapulmonary TB (EPTB) and the distribution of its different manifestations. There is an important relationship between HIV and EPTB [13, 14] : EPTB constitutes 40-68% of all TB cases among HIV-infected patients, whereas only 15-20% of all TB cases in immunocompetent patients is EPTB [15] [16] [17] [18] .
Of important note is that most data on EPTB are from countries outside of Sub-Saharan Africa, where the global burden of HIV is concentrated. It is crucial to know more about the epidemiology of EPTB in South Africa. Extrapulmonary manifestation of TB is generally associated with a challenging diagnosis, a considerable diagnostic delay [19, 20] and unrecognized and undiagnosed infection [21] , all contributing to the documented poor prognosis of EPTB. The aim of this study is to determine the effect of scale-up of the ART programme on the epidemiology of EPTB in a rural population in South Africa, in order to understand the TB epidemic in a better way and to inform TB control efforts and policy design.
METHODS

Study design and setting
This is a retrospective record review of patients initiated on treatment for EPTB in 2009 and 2013 at four public hospitals in rural Mopani District, Limpopo Province, South Africa. In this province the adult HIV prevalence is 12%. We chose the years 2009 and 2013 as these reflect different phases in ART scale-up in South Africa and to allow for TB treatment outcome data to be included in this analysis. In 2009 the ART programme in South Africa was quite small, doctor-driven, and provided at accredited healthcare facilities only. The CD4 count threshold for ART initiation at that time was 200 cells/mm 3 ; this was changed in 2010 to 350 cells/mm 3 and accompanied by large scale-up of the ART programme through implementation of the nurse-managed ART programme [22] .
In our setting, EPTB is almost exclusively diagnosed at hospitals as diagnostic resources and clinical expertise (doctor) are required that is not available at the primary healthcare level. We included all seven hospitals (6 district and 1 regional hospital) in this evaluation. However, the complete required TB register could not be retrieved at three district hospitals and these were excluded from further evaluation.
We obtained ethical approval from the Human Research Committee at the University of Witwatersrand (reference no. M141012).
Data collection
Data were collected for the months January to October of the years 2009 and 2013 from two sources: the routine TB register and clinical records. The complete TB register could not be retrieved for November and December for all hospitals.
In South Africa each healthcare facility has a paper-based TB register in which all individuals initiated on TB treatment are recorded by the TB nurse. We recorded the total number of patients treated for TB and the number treated for EPTB, and for which type, as defined by using the International Statistical Classification of Diseases and Related Health Problems 10 th Revision (ICD-10) [23] . Other information obtained from this register includes data on age, sex, history of TB treatment, HIV co-infection, ART usage at treatment initiation, CD4 count at treatment initiation and treatment outcome.
In addition to the information from the TB registers, clinical records of patients treated for EPTB were retrieved and reviewed by JCH, LR and NM using a standardized data collection sheet. We collected additional information on investigations, diagnosis, treatment and comorbidity (e.g. HIV).
We used this additional data to validate the data from the TB register and to determine evidence for the given diagnosis.
Definitions
All ICD-10 codes recorded in the TB register were classified as EPTB except for A15.0 (tuberculosis of lung, confirmed by sputum microscopy), A16.2 (tuberculosis of lung, without mention of bacteriological of histological confirmation) and A16.7 (primary respiratory tuberculosis without mention of bacteriological or histological confirmation) which together conferred the group of PTB.
For each retrieved clinical record, two investigators (JCH, RPHP) determined the level of evidence available to support the diagnosis written in the clinical record and classified this as 'good evidence', 'limited evidence and 'no evidence'. In case of difference between the investigators, a third investigator (LR) decided. We used the National Tuberculosis Guideline 2014 [24] to determine the level of evidence (Supplementary Table S1 ). In this context, the comment 'miliary TB picture on Xray' was defined as miliary TB whereas 'disseminated TB' was defined as EPTB at multiple extrapulmonary sites.
Data analysis
All data were double-entered in Epi Info Version 3.5.4. (Centers for Disease Control and Prevention, Atlanta, USA) and analyzed using IBM SPSS Statistics Version 22.0 (IBM Corporation, New York, USA).
Routine descriptive statistics of the study population are provided using total number with proportion (%), median (range) and mean (standard deviation). The number of patients treated for EPTB and the distribution of EPTB forms was compared between 2009 and 2013 using the Z-test for proportions; this was done both for data retrieved from the TB registers and the patients' clinical records. The 95% confidence intervals (CI) were calculated using the method described by Wilson. To determine the incidence of EPTB at population level, the total population was calculated using available census data for individuals residing in the catchment area hospitals included in this evaluation (997650 individuals in 2011) [25] . A p-value of <0.05 was considered significant.
RESULTS
TB cases over time in the district
The total number of TB cases recorded in the TB register decreased by 13% (95% CI 11 -15%) from 
Demographic characteristics of patients treated for EPTB over time
The decrease in EPTB cases was based on a 21% decrease among adult individuals (from 373 in 2009 to 295 in 2013) ( Table 1) . However, although the absolute number is small, the number of children compared to those not on ART and remained the same between both years. For both years 80% of the treatment outcome was missing, mainly due to patients moving out to primary health clinics for follow-up. 
Distribution of types of EPTB
TB pleural effusion is the most common type of EPTB (53% in 2009 vs. 56% of all cases in 2013), followed by miliary TB (30% respectively 14%) (Figure 2a) . There was no significant change of the proportion of individuals treated for pleural effusion over time, but the number of cases of miliary TB decreased significantly from 119 to 49 (p < 0.01). The proportion of individuals treated for miliary TB that had a positive HIV status remained the same ( 89% vs. 80%, p = 0.15, table 2). The ART-coverage increased from 26% to 62% (p < 0.01). The median CD4-count remained very low for both years and both HIV-infected people on ART and not on ART amongst these patients with miliary TB. 
Diagnosis in TB registers vs. clinical records
We 
DISCUSSION
This is the first study that demonstrates a significant decrease in cases of EPTB in the context of ART scale-up in Africa. We show that the decrease in EPTB in our setting is similar to that of PTB and that the epidemiological profile of EPTB has changed. We used routinely available data of the TB register in this analysis and confirmed the observation by review of patients' clinical records to assess data quality issues and concerns regarding the clinical diagnostic evidence of diagnosis.
The HIV epidemic has been a major driver of the TB epidemic in Africa [4] . In that context, provision of ART is an important intervention to reduce the burden of TB. Several studies suggest that the TB control programme might benefit from an expanded access to ART in HIV-infected patients [9, 26] . We observed a 13% decline in TB cases between 2009 and 2013 in the context of the ART scale-up in a rural South African district. This in line with other studies: a study from Malawi reported a decrease of 33% of TB cases five years after introduction of ART [27] and in Cape Town the TB notification rate declined by 16% [10] . Futhermore, Nanoo et al. reported a decline of microbiologically confirmed PTB of 9% between 2008 and 2012 in South Africa in the context of the ART scale-up [11] , similar to the 13% decrease in PTB we observed.
We provide the first report that shows a similar decline in cases of EPTB as for PTB in our setting. Despite that this is a promising observationwe hoped to find a decline in EPTB that would be larger than for PTB. HIV has a stronger relationship with EPTB than PTB [14, 28] . Gomer et al reports an Odds Ratio (OR) 2.15 (95% CI 2.09-2.21) of HIV infection amongst EPTB comparing to PTB. A possible explanation of our findings is an overestimation of the decline in PTB patients, because we only analyzed hospital data and did not include data from primary healthcare (PHC) settings.
Generally, patients diagnosed with PTB at the hospital have more severe illness than the uncomplicated cases at PHC facilities. A shift towards less severe TB disease as result of ART could have let to more individuals being diagnosed with PTB outside the hospital. The introduction of GeneXpert in 2010 as first-line diagnostic for TB might have contributed to more diagnosis of PTB in the PHC as well [24, 29] .
We observed an increase in EPTB amongst children. Although this is surprising, especially amongst HIV-uninfected children, we were not able to relate this increase to any specific hospital or the pattern in the distribution of EPTB. We do not have a clear explanation for this, but increased diagnostic awareness among local doctors may not be ruled out. In our study the median CD4-count remained the same between both years. This illustrates the strong association of EPTB with low CD4 count in HIV-infected individuals. Although population risk for EPTB was reduced following ART scaleup (as reflected in decreased number of EPTB cases), HIV-infected patients are still at risk of getting EPTB when their CD4 counts are low (ART not started, non-compliance to ART, on ART for a short time) [21] .
The most common type of EPTB was TB pleural effusion followed by miliary TB. TB lymphadenitis was only diagnosed in 6% of the cases in 2009 and 9% of the cases in 2013. Moreover, in patients treated for TB lymphadenitis there is a low frequency of good documentation supporting this diagnosis in the patient records. Other studies report TB pleural effusion [26, 28, 30, 31] or TB lymphadenitis [15, 32] as the most common type of EPTB. This suggests that there is under recording.
The under diagnosis of TB lymphadenitis in our region warrants attention.
The absolute number of patients with TB pleural effusion decreased, but it still is the site of EPTB for half of the patients. There are several reasons why there may not be a decrease in the proportion of patients with pleural effusion. The definitive diagnosis is difficult to achieve [33] , especially because it requires invasive investigations and GeneXpert has a poor sensitivity in diagnosing TB pleural effusion [34, 35] . This is also illustrated in our review of clinical records where only 40% had good evidence for the diagnosis. Besides this, pleural effusion can be reactive to PTB, where it should be classified as PTB instead of EPTB. Finally, the possibility of misdiagnosis of pleural effusion of other aetiology as EPTB (e.g. heart failure, malignancy) cannot be excluded, especially in settings with limited resources.
The HIV epidemic has been associated with a strong increase in miliary and disseminated TB, especially among individuals with severe immunosuppression (CD4 <200 cells/µl) [36, 37] . HIVinfection is a strong predictor for blood stream infection (BSI) with Mycobacterium tuberculosis [38] .
Our data show a significant reduction in both miliary TB and disseminated TB associated with ART scale-up. This suggests that ART scale-up is decreasing the risk of BSI in HIV-infected patients, which has been reported before [39] .
Although we describe an encouraging decline in EPTB in general, and in miliary TB and disseminated TB in particular, we observed a significant increase in the small number of TB of bones and joints and cases of TB meningitis. One study reports a rising incidence of TB of bones and joints; none of the patients was HIV-infected [40] . This may implicate that TB of bones and joints is not related to HIV as strongly as most other types of EPTB and probably other risk factors are more important. HIV-infected patients are at higher risk for TB meningitis compared to HIV-uninfected patients [41] , which led to our hypothesis TB meningitis would decline in the context of the ART-scale up. However, our data show an increase, which is similar for all four hospitals, while the evidence for TB meningitis in the patient's clinical record remained the same between both years. This trend needs attention and should be investigated in further detail, as TB meningitis is a predictor of mortality amongst HIV-infected patients with EPTB [42] .
This study has several limitations. First, we performed a retrospective record review using data from the hospital TB registers. Due to the general lack of resources and skills to conduct a prospective study, we conducted a retrospective analysis of routinely available data. Data quality issues are always a concern when using routine programme data, but by analyzing both the TB registers as well as the clinical records we attempted to minimize this effect in our interpretation. TB is a notifiable disease in South Africa and everyone initiated on TB treatment has to be recorded, resulting in a little recording bias when analyzing the data from the TB register. However, poor record keeping in files is a well-known phenomenon in African healthcare setting, hence it is not suprising that recording of evidence of diagnosis is not optimal. These diagnostic issues do not mean that tests were not performed or that the diagnosis is incorrect. It reflects both the quality of record keeping as well as the quality of clinical assessment and diagnosis. Despite some disconcordance between TB register and clinical records , the trends were similar, providing a good reflection of what is happening over time in our setting. Besides this, the level of ART adherence was not assessed and we cannot exclude a possible influence of this on the epidemiology of EPTB. We also do not have data on the time elapsed between ART initiation and EPTB, so we could not determine the role of immune reconstitution in the epidemiology. Furthermore, we could not retrieve and provide any accurate information about prognosis and follow up. We choose 2013 as year after the start of the ART scale-up in order to get data about treatment outcome and follow-up. Unfortunately data about follow up was missing in most of the patients, mainly due to referral back to the primary health care.
This is a missed opportunity as ART has been associated with a reduced mortality rate among PTB patients and it would have been important to assess this association in the context of EPTB as well [43] [44] [45] . Despite this limitations, this is the first study on this topic, providing insight in the epidemiology of EPTB in the context of the ART scale-up. Prospective data is needed to confirm the observed trends.
Despite the documented reduction in EPTB associated with strong scale-up of ART services in our rural district, a considerable burden of disease remains. Prevention of infection, early detection of TB, accurate diagnosis and treatment, and active screening, especially amongst HIV-infected patients, are necessary to control the TB epidemic [44] [45] . In addition, more awareness is required for the documentation of EPTB data. There should also be awareness for the diagnosis and clinical management of EPTB, especially for the types of EPTB where laboratory testing is needed (e.g. TB lymphadenitis, TB pleural effusion).
In conclusion, we provide the first data that show an encouraging decrease in EPTB between 2009 and 2013, similar to PTB, in the context of the ART scale-up in Africa. Despite this reduction a considerable epidemic remains, resulting in an ongoing broad public health implication of TB. Besides this, the epidemiology of EPTB is changing, which shows the need for educated health care workers and expansion of the TB programme in rural South Africa. 
